Stopping GLP-1 drugs before pregnancy leads to more weight gain
New research shows that women who halt GLP-1 medications near conception face greater gestational weight gain and elevated…
Regenerative medicine offers a pathway toward curing type 1 diabetes
Type 1 diabetes (T1D) is an autoimmune disorder characterized by the specific destruction of insulin-producing pancreatic β-cells. While…
Searches for “Ozempic face” surge as people look for filler-based solutions
New search data reveal that as interest in “Ozempic face” surges, people increasingly turn to nonsurgical fillers rather…
Study compares GLP-1 drug benefits and finds substantial variation in clinical effects
A new umbrella review reveals how GLP-1 therapies shape cardiovascular, renal, and metabolic outcomes in type 2 diabetes…
Tirzepatide may only temporarily suppress brain activity involved in “food noise”
A rare glimpse into the brain activity of a patient with obesity and loss of control eating on…
Off-label GLP-1 use highlights the cultural pressures driving body anxieties
A new sociomedical perspective shows how off-label use of GLP-1 drugs for slimness is redefining what counts as…
GLP-1 drugs linked to improved survival in colon cancer patients
A new University of California San Diego study offers compelling evidence that glucagon-like peptide-1 (GLP-1) receptor agonists –…
Diabetes remission possible with GLP-1 drugs, Italian study confirms
Real-world data from over 14,000 Italian adults reveal that GLP-1 receptor agonists can induce remission in type 2…
Exercise can mitigate depression-like behaviors induced by high-fat, high-sugar diets
Researchers led by Professor Yvonne Nolan at University College Cork have identified specific metabolic pathways through which exercise…
SMOC1 gene plays a surprising role in the development of type 2 diabetes
Scientists at City of Hope®, one of the largest and most advanced cancer research and treatment organizations in…
Study shows prediabetes remission does not always require weight loss
New evidence shows that restoring normal glucose regulation can shield against diabetes even without weight loss, reshaping prevention…
Study:Half of adults without diabetes taking weight-loss drug discontinue treatment within a year
The new class of anti-obesity drugs, glucagon-like peptide-1 receptor agonists (GLP-1RAs), is proving remarkably effective at helping individuals…